Cargando…

Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA

BACKGROUND AND OBJECTIVE: Suicidal ideation or behavior are core symptoms of major depressive disorder (MDD). This study aimed to understand heterogeneity among patients with MDD and acute suicidal ideation or behavior. METHODS: Adults with a diagnosis of MDD on the same day or 6 months before a cla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhdanava, Maryia, Voelker, Jennifer, Pilon, Dominic, Cornwall, Tom, Morrison, Laura, Vermette-Laforme, Maude, Lefebvre, Patrick, Nash, Abigail I., Joshi, Kruti, Neslusan, Cheryl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166679/ https://www.ncbi.nlm.nih.gov/pubmed/34043148 http://dx.doi.org/10.1007/s40273-021-01042-5

Ejemplares similares

Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitate
por: Morrison, Laura, et al.
Publicado: (2023)

Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
por: Pilon, Dominic, et al.
Publicado: (2022)

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
por: Zhdanava, Maryia, et al.
Publicado: (2020)

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression
por: Zhdanava, Maryia, et al.
Publicado: (2021)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents
por: Pilon, Dominic, et al.
Publicado: (2022)

Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study
por: Alberts, Mark, et al.
Publicado: (2023)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States
por: Zhdanava, Maryia, et al.
Publicado: (2023)

Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
por: Alberts, Mark, et al.
Publicado: (2023)

Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study
por: Alberts, Mark, et al.
Publicado: (2023)

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab
por: Kavati, Abhishek, et al.
Publicado: (2018)

Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States
por: Williams, Paul V., et al.
Publicado: (2018)

Critical appraisal of major depression with suicidal ideation
por: Pompili, Maurizio
Publicado: (2019)

Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior
por: Canuso, Carla M., et al.
Publicado: (2021)

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
por: Pilon, Dominic, et al.
Publicado: (2017)

Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform
por: Borentain, Stephane, et al.
Publicado: (2020)

Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors
por: Donga, Prina, et al.
Publicado: (2022)

Suicidal ideation and ECT, ECT and suicidal ideation: A register study
por: Sienaert, Pascal, et al.
Publicado: (2022)

Clinical consensus regarding the importance of rapid reduction in depressive symptoms in major depressive disorder with acute suicidal ideation or behavior (MDSI)
por: Borentain, S., et al.
Publicado: (2022)

Relationships between anhedonia, suicidal ideation and suicide attempts in a large sample of physicians
por: Loas, Gwenolé, et al.
Publicado: (2018)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Suicidal ideation and attempts in patients with major depression: Sociodemographic and clinical variables
por: Srivastava, A.S., et al.
Publicado: (2005)

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
por: Bai, Shunjie, et al.
Publicado: (2021)

Risk of suicide ideation in comorbid substance use disorder and major depression
por: Onaemo, Vivian N., et al.
Publicado: (2022)

Suicidal Ideation in Major Depressed Individuals: Role of Type D Personality
por: Laoufi, Mokhtar Abdelhakim, et al.
Publicado: (2022)

Suicidal Ideation and Electroconvulsive Therapy: Outcomes in Adolescents With Major Depressive Disorder
por: Cai, Haipeng, et al.
Publicado: (2023)

Suicidal Ideations in Major Depressed Subjects: Role of the Temporal Dynamics of Anhedonia
por: Darquennes, Gil, et al.
Publicado: (2023)

SUICIDAL IDEATION AMONG OLDER ADULTS LIVING WITH CHRONIC ILLNESS
por: Poe, Abigail, et al.
Publicado: (2022)

Suicide and suicidal ideation in the times of the Covid-19 pandemic: A scientometric analysis
por: Palod, Rajat Jagdish, et al.
Publicado: (2022)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Suicidal ideation and suicide attempts among asthma
por: Chung, Jae Ho, et al.
Publicado: (2016)

Cognitive Control in Suicide Ideators and Suicide Attempters
por: Brokke, Silje Støle, et al.
Publicado: (2020)

Association between cognitive deficits and suicidal ideation in patients with major depressive disorder
por: Pu, Shenghong, et al.
Publicado: (2017)

Dienogest-induced major depressive disorder with suicidal ideation: A case report
por: Lee, Sang Min, et al.
Publicado: (2021)

Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2023)

An unusual cause of suicidal ideations
por: Landau, Daniel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rqko1nde6eonktvmkdeni7li20